Antineoplastic properties. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured HL-60 Cells Cell Line HT29 Cells Cells, Cultured Lymphocytes K562 Cells Kidney

Organisms8

Narcissus Aster Plant Olacaceae Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred DBA Mice, Inbred C57BL

Diseases32

Neoplasms Leukemia P388 Leukemia L1210 Neoplasms, Experimental Sarcoma 180 Phlebitis Carcinoma, Ehrlich Tumor Breast Neoplasms Lung Neoplasms Colonic Neoplasms Prostatic Neoplasms Ovarian Neoplasms Leukemia Lymphoma Mammary Neoplasms, Experimental Drug-Related Side Effects and Adverse Reactions Brain Neoplasms Adenocarcinoma Glioma Neovascularization, Pathologic Leukemia, Experimental Multiple Myeloma Colorectal Neoplasms Leukopenia Vomiting Melanoma Neoplasm Metastasis Nausea Bone Neoplasms Melanoma, Experimental Cardiomyopathies Kidney Neoplasms

Chemicals and Drugs127

Antineoplastic Agents Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Antineoplastic Agents, Alkylating Doxorubicin Antimetabolites, Antineoplastic Phospholipid Ethers Ellipticines Gallium Bryostatins Thiadiazines Amaryllidaceae Alkaloids Cisplatin Paclitaxel Bibenzyls Sulindac Daunorubicin Lactones Depsipeptides 6-Mercaptopurine Epothilones Cyclophosphamide Amsacrine Fluorouracil Vanadium Compounds Etoposide Prodrugs Methotrexate Enzyme Inhibitors Hazardous Substances Ancitabine Thiosemicarbazones Floxuridine Bleomycin Macrolides 2-Propanol Aminoacridines Vincristine Carmustine Cytarabine Topoisomerase II Inhibitors Farnesyltranstransferase Drugs, Investigational Isocoumarins Nitrogen Mustard Compounds Camptothecin Dioxoles Suramin Alkaloids Plant Extracts Mitomycin Topoisomerase I Inhibitors Azacitidine DNA Adducts DNA Topoisomerases, Type II Anti-Inflammatory Agents, Non-Steroidal Nitrosourea Compounds Pyrones Pyrazines Caspases Isoquinolines Hydrazones Sulfonamides DNA, Neoplasm Alkylating Agents Razoxane Phosphorylcholine Organoplatinum Compounds Octreotide Glutathione Transferase Lomustine Piperazines Mitomycins RNA, Messenger Stilbenes Dehydroascorbic Acid DNA Anthracyclines P-Glycoprotein Intercalating Agents Benzoquinones Histone Deacetylase Inhibitors Topotecan Phenanthridines Vinblastine Diphosphonates Tetrahydroisoquinolines Caspase 3 Deoxycytidine Taxoids Boronic Acids Glutathione Mitoxantrone Annexin A5 Drug Carriers Hydrazines Melphalan Proto-Oncogene Proteins c-bcl-2 Tubulin Modulators Thymidylate Synthase Anticarcinogenic Agents Angiogenesis Inhibitors Pyrroles Thiazoles Sesquiterpenes Reactive Oxygen Species Neoplasm Proteins Ifosfamide DNA Topoisomerases, Type I Cyclooxygenase Inhibitors Hydroxamic Acids Antibodies, Monoclonal, Humanized Radiation-Sensitizing Agents Protein Kinase Inhibitors O(6)-Methylguanine-DNA Methyltransferase Peptides, Cyclic Organometallic Compounds Multidrug Resistance-Associated Proteins Pyridines Fatty Acid Synthases Proteasome Inhibitors Antibodies, Monoclonal Deoxyguanosine Dexamethasone Colchicine Dacarbazine Purines

Analytical, Diagnostic and Therapeutic Techniques and Equipment34

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Gloves, Protective Protective Devices Xenograft Model Antitumor Assays Equipment and Supplies, Hospital Protective Clothing Drug Evaluation, Preclinical Drug Evaluation Neoplasms, Experimental Neoplasm Transplantation Inhibitory Concentration 50 Drug Compounding Antineoplastic Protocols Tumor Stem Cell Assay Comet Assay Drug Administration Schedule Lethal Dose 50 Clinical Trials as Topic Mutagenicity Tests Blotting, Western Mammary Neoplasms, Experimental Flow Cytometry Transplantation, Heterologous Drug Carriers Transfection Leukemia, Experimental Drug Delivery Systems Tumor Burden Injections, Intraperitoneal Infusions, Intravenous Treatment Outcome Chromatography, High Pressure Liquid Melanoma, Experimental

Phenomena and Processes32

Apoptosis Drug Synergism Cell Survival Dose-Response Relationship, Drug Dental Physiological Processes Cell Proliferation Drug Resistance, Neoplasm Cell Division Cell Cycle Molecular Structure DNA Damage Inhibitory Concentration 50 Drug Resistance, Multiple Drug Resistance Time Factors Drug Interactions DNA Adducts Lethal Dose 50 Gene Expression Regulation, Neoplastic Biotransformation Metabolic Detoxication, Drug Structure-Activity Relationship Kinetics Cell Death Stereoisomerism Transfection Sister Chromatid Exchange Signal Transduction G2 Phase Phosphorylation Transcription, Genetic Tissue Distribution

Disciplines and Occupations2

Oncology Nursing Veterinary Medicine

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Information Science1

Molecular Sequence Data

Named Groups5

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses Pharmacists

Health Care18

Occupational Exposure Medical Secretaries Oncology Nursing Equipment Contamination Decontamination Nursing Staff, Hospital Environmental Monitoring Personnel, Hospital Antineoplastic Protocols Pharmacies Oncology Service, Hospital Nurses Hospitals Pharmacists Clinical Trials as Topic Cancer Care Facilities Safety Management Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Named Groups Health Care

Antineoplastic Agents Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Antineoplastic Agents, Alkylating Drug Screening Assays, Antitumor Doxorubicin Neoplasms Leukemia P388 Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Phospholipid Ethers Cell Line, Tumor Apoptosis Ellipticines Gallium Bryostatins Thiadiazines Gloves, Protective Tumor Cells, Cultured Amaryllidaceae Alkaloids Drug Synergism Narcissus Aster Plant Cell Survival Cisplatin Leukemia L1210 Occupational Exposure Olacaceae Dose-Response Relationship, Drug Paclitaxel Bibenzyls Medical Secretaries Oncology Nursing Laundering Sulindac Protective Devices Dental Physiological Processes Xenograft Model Antitumor Assays Daunorubicin Lactones Cell Proliferation Drug Resistance, Neoplasm Equipment and Supplies, Hospital Protective Clothing Depsipeptides Drug Evaluation, Preclinical Cell Division Equipment Contamination 6-Mercaptopurine Epothilones Cell Cycle Drug Evaluation Cyclophosphamide Amsacrine HL-60 Cells Fluorouracil Decontamination Neoplasms, Experimental Vanadium Compounds Neoplasm Transplantation Sarcoma 180 Phlebitis Molecular Structure Etoposide Prodrugs Nursing Staff, Hospital Methotrexate Mice, Nude DNA Damage Environmental Monitoring Enzyme Inhibitors Hazardous Substances Ancitabine Inhibitory Concentration 50 Thiosemicarbazones Carcinoma, Ehrlich Tumor Personnel, Hospital Floxuridine Bleomycin Breast Neoplasms Macrolides Drug Compounding 2-Propanol Antineoplastic Protocols Aminoacridines Tumor Stem Cell Assay Lung Neoplasms Colonic Neoplasms Vincristine Pharmacies Carmustine Cytarabine Topoisomerase II Inhibitors Drug Resistance, Multiple Farnesyltranstransferase Oncology Service, Hospital Comet Assay Drug Administration Schedule Drugs, Investigational Isocoumarins

No FAQ available that match "antineoplastic properties"